Javara is an integrated research organization (IRO) that partners with healthcare organizations to deliver clinical trials at the point of care through integrated research staff and centralized operations. Founded in 2018 and headquartered in Winston-Salem, N.C., the company reports access to over 5 million patients across seven states. Its model leverages trusted physician relationships to drive high enrollment and retention and standardized processes to accelerate study start-up and quality outcomes. The company recently secured a Series C growth investment from earlier and new community-based investors to support expansion. Proceeds will support growth of current and new healthcare partnerships and entry into therapeutic specialties including oncology, CNS, and neurology via localized clinical research collaborations. Founders Jennifer Byrne, Linda McCarty, and Amanda Wright say the funding will help double both patient and physician reach and advance Clinical Research as a Care Option (CRAACO). Javara is an integrated research organization that partners with large healthcare systems to broaden access to more diverse patient populations for clinical trials. Unlike traditional clinical research organizations, Javara embeds clinical research professionals within partner clinics to reduce inequities, inefficiencies, and trial delays. Its partners include Atrium Health Wake Forest Baptist, Mankato Clinic, Nevada Health Centers, Privia Medical Group, and Tryon Medical Partners. The company recently raised $9.4 million by selling debt and said it will use the proceeds to deepen relationships with current healthcare partners and broaden into more therapeutic areas of research. Javara has more than 250 employees and was ranked No. 94 on Inc. magazine’s Fast 5000 list with three-year revenue growth of 5,070%. Jennifer Byrne has been CEO since June 2018 and previously led PMG Research. Javara is an integrated research organization and a pioneer of Clinical Research as a Care Option (CRAACO), partnering with large healthcare organizations to embed research teams and infrastructure at the point of care. The company integrates centralized resources and standardized operations to accelerate study start-up, improve enrollment and retention, and deliver higher-quality data for sponsors. Javara works with an extensive network of pharma, biotech and contract research organizations to expand patient access to trials through trusted physicians. The company emphasizes increasing patient diversity and retention by introducing trials in familiar, convenient clinical settings and providing a high-touch support team. Javara intends to leverage new capital to drive geographic expansion and technological advancements to further integrate clinical research into the healthcare ecosystem and reach more patients. The announcement did not disclose revenue or other financial operating metrics.

Total raised

$9M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Nov 2023